Correlation Between Hansa Biopharma and Cantargia
Can any of the company-specific risk be diversified away by investing in both Hansa Biopharma and Cantargia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hansa Biopharma and Cantargia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hansa Biopharma AB and Cantargia AB, you can compare the effects of market volatilities on Hansa Biopharma and Cantargia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hansa Biopharma with a short position of Cantargia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hansa Biopharma and Cantargia.
Diversification Opportunities for Hansa Biopharma and Cantargia
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Hansa and Cantargia is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Hansa Biopharma AB and Cantargia AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cantargia AB and Hansa Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hansa Biopharma AB are associated (or correlated) with Cantargia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cantargia AB has no effect on the direction of Hansa Biopharma i.e., Hansa Biopharma and Cantargia go up and down completely randomly.
Pair Corralation between Hansa Biopharma and Cantargia
Assuming the 90 days trading horizon Hansa Biopharma AB is expected to generate 0.77 times more return on investment than Cantargia. However, Hansa Biopharma AB is 1.3 times less risky than Cantargia. It trades about -0.08 of its potential returns per unit of risk. Cantargia AB is currently generating about -0.13 per unit of risk. If you would invest 4,900 in Hansa Biopharma AB on November 2, 2024 and sell it today you would lose (1,578) from holding Hansa Biopharma AB or give up 32.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hansa Biopharma AB vs. Cantargia AB
Performance |
| Timeline |
| Hansa Biopharma AB |
| Cantargia AB |
Hansa Biopharma and Cantargia Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hansa Biopharma and Cantargia
The main advantage of trading using opposite Hansa Biopharma and Cantargia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hansa Biopharma position performs unexpectedly, Cantargia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cantargia will offset losses from the drop in Cantargia's long position.| Hansa Biopharma vs. Oncopeptides AB | Hansa Biopharma vs. ExpreS2ion Biotech Holding | Hansa Biopharma vs. BioInvent International AB | Hansa Biopharma vs. Zealand Pharma AS |
| Cantargia vs. Hansa Biopharma AB | Cantargia vs. Oncopeptides AB | Cantargia vs. BioArctic AB | Cantargia vs. Alligator Bioscience AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |